Diabetic retinopathy is an eye complication of diabetes that damages the retina and can lead to vision loss. Many people with diabetic retinopathy have no early symptoms, but blurred vision, dark spots, or trouble seeing at night can develop. It progresses over years, and risk rises with longer duration of diabetes and higher blood sugar, blood pressure, and cholesterol. People with diabetic retinopathy are often adults with type 1 or type 2 diabetes, and regular eye exams can catch changes early. Treatment may include tighter blood sugar control, blood pressure and cholesterol management, laser therapy, eye injections, or surgery, and most people do better when care starts early.
Overview
Diabetic retinopathySymptoms
Early symptoms of diabetic retinopathy are often absent. As it advances, people may notice blurred or fluctuating vision, floaters, dark or empty areas, trouble seeing at night or colors, and sudden vision loss. Seek urgent care for sudden changes.
Outlook and prognosis
Many people with diabetic retinopathy keep useful vision, especially when blood sugar, blood pressure, and cholesterol stay well managed. Regular dilated eye exams and timely treatments can slow or halt vision loss. Severe stages raise risks, but earlier detection improves outcomes.
Causes and risk factors
Diabetic retinopathy arises from long-term high blood sugar damaging retinal vessels. Risk rises with longer diabetes duration, poor glucose control, high blood pressure, high cholesterol, kidney disease, pregnancy, smoking, obesity, family history, certain ethnic backgrounds, and limited access to screening.
Genetic influences
Genetics plays a modest role in diabetic retinopathy risk, influencing susceptibility, severity, and how quickly changes progress. Still, blood sugar, blood pressure, and duration of diabetes matter more. Family history can guide screening, but routine clinical management remains the priority.
Diagnosis
Doctors diagnose diabetic retinopathy during a comprehensive dilated eye exam, looking for leaking vessels, hemorrhages, and swelling. Optical coherence tomography and fluorescein angiography can confirm severity. Regular screening supports early diagnosis of diabetic retinopathy, even before vision changes.
Treatment and drugs
Treatment for diabetic retinopathy focuses on protecting sight and preventing bleeding or swelling in the retina. Plans often combine tight blood sugar, blood pressure, and cholesterol control with eye therapies like anti-VEGF injections, laser treatment, or vitrectomy surgery when needed. Regular dilated eye exams guide timing and choice of treatment.
Symptoms
You might notice nothing at first, then vision can blur or shift from day to day. Symptoms vary from person to person and can change over time. Early symptoms of diabetic retinopathy can include blurry or fluctuating vision, new floaters, and trouble seeing in dim light, but many people have no symptoms until changes are more advanced. Vision may clear, then blur again, making reading, driving at night, or recognizing faces more challenging.
Many have no noticeable changes at first. Vision can seem normal even as changes are happening in the back of the eye.
With diabetic retinopathy, vision may blur and sharpen over hours or days. Reading fine print or phone screens can start to feel harder.
You may see small dark specks, strings, or cobweb-like shapes drifting across your sight. People with diabetic retinopathy sometimes notice more of these against a bright sky or a white wall.
Blank or dark areas can show up in part of what you see. Faces or signs may be missing pieces or look partly blocked.
How people usually first notice Diabetic retinopathy?
Many people first notice diabetic retinopathy when their vision starts acting “in and out of focus,” with blurry spots, trouble reading, or seeing floaters or dark strings that drift across their sight. Others notice vision changes after blood sugar swings or during pregnancy, or they’re told at a routine eye exam that tiny blood vessel changes are visible in the retina even before symptoms appear. For many, the earliest and most reliable “first signs of diabetic retinopathy” are actually found during a dilated eye exam, where an eye doctor can spot leakage, swelling, or small hemorrhages long before day-to-day vision is affected.
Types of Diabetic retinopathy
Diabetic retinopathy has well-recognized stages that affect vision in different ways over time. Early on, many people have no symptoms, while later stages can cause blurry vision, trouble seeing at night, or sudden floaters after a busy day or long drive. The balance of symptoms can shift over time. Here are the main types to know about, including how symptoms can differ and what people mean by “types of diabetic retinopathy.”
Mild nonproliferative
Often no symptoms or subtle blurring, especially when blood sugars swing. You might notice mild difficulty focusing after reading or screen time. Regular eye exams can spot tiny vessel changes before vision shifts.
Moderate nonproliferative
Blurry or fluctuating vision becomes more noticeable. Colors may look a bit washed out, and night driving can feel harder. Symptoms may come and go with glucose changes.
Severe nonproliferative
Vision can dim or blur more consistently. Dark spots or areas of missing vision may appear, and reading small print gets harder. Headaches or eye strain after close work are common.
Proliferative retinopathy
New fragile vessels can bleed, causing sudden floaters, streaks, or a curtain-like shadow. Vision may drop quickly after a bleed. This stage carries a higher risk of scarring and vision loss.
Diabetic macular edema
Central vision blurs, making faces, phone text, or fine detail harder to see. Colors can look dull, and straight lines may appear wavy. Reading and driving can be especially affected even in earlier stages.
What genetics can tell you about symptoms
Certain gene variants, like in VEGF and AKR1B1, can make retinal blood vessels leak or grow abnormally, raising the chance of earlier, more severe vision changes. Variants in EPO, RAGE, and HIF1A may heighten inflammation and swelling, worsening blurry vision and floaters.
Causes and risk factors
Diabetic retinopathy is driven by long-term high blood sugar that damages the tiny blood vessels in the eye.
Risk factors for diabetic retinopathy include many years of diabetes, poor blood sugar control, high blood pressure, high cholesterol, and kidney disease.
Smoking, low physical activity, and excess body weight raise risk, and missing regular eye exams can let diabetic retinopathy progress unchecked.
Family history and genetic susceptibility can raise risk, and patterns can vary across different ethnic groups.
Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Diabetic retinopathy can creep up quietly, then interfere with reading, driving, or recognizing faces. Knowing what raises risk helps you and your care team catch changes early and plan checkups. Doctors often group risks into internal (biological) and external (environmental). Understanding these helps you act sooner if you notice early symptoms of diabetic retinopathy.
The longer you have diabetes, the higher the chance of diabetic retinopathy. Ongoing exposure to high sugar levels slowly strains the tiny vessels in the retina.
Consistently high glucose harms retinal vessels and speeds damage. Even intermittent spikes can add stress between checkups.
Raised pressure, known medically as hypertension, injures blood vessel walls. This makes retinal leakage and swelling more likely.
Elevated cholesterol or triglycerides can worsen vessel damage. This may increase deposits and swelling linked with diabetic retinopathy.
Genetic risk factors
Genetics plays a meaningful role in who develops diabetic retinopathy and how quickly it progresses. Research points to several genetic risk factors for diabetic retinopathy, from common variants with small effects to rare changes seen in families. Risk is not destiny—it varies widely between individuals. Most involve pathways that control blood vessel growth, inflammation, and how retinal cells handle sugar-related stress.
Family history: Having close relatives who had diabetic retinopathy raises your odds of developing it. This pattern suggests inherited susceptibility running through families.
Ancestry background: Some ancestry groups carry higher frequencies of risk variants tied to retinopathy. Genetic backgrounds linked to African, Hispanic/Latino, or South Asian ancestry have shown higher risk in studies, though individual risk varies.
VEGF gene variants: Changes near the VEGF gene can amplify signals that drive fragile new blood vessels in the retina. Several variants have been repeatedly associated with higher risk or more severe disease.
Aldose reductase gene: Variants in the AKR1B1 (aldose reductase) gene affect how retinal cells handle excess sugar and oxidative stress. Some versions are linked to earlier onset or faster progression of diabetic retinopathy.
RAGE pathway genes: Changes in the AGER (RAGE) gene can alter responses to sugar-related byproducts and inflammation in retinal tissue. These variants have been connected with greater risk in multiple populations.
ACE gene variants: The ACE insertion/deletion variant influences vessel tone and growth signals in the eye. Certain forms are tied to increased odds of diabetic retinopathy, with effects that may differ by population.
NOS3 gene variants: Differences in the endothelial nitric oxide synthase (NOS3) gene can change how retinal blood vessels dilate and resist stress. Several studies link these variants to retinopathy risk or severity.
Inflammation genes: Variants in immune signaling and cell-adhesion genes, such as ICAM1 or TNF, may heighten retinal inflammation. This can make vessels leakier and more vulnerable to damage.
Polygenic risk score: Many small genetic effects add up, and researchers are building tools that combine them into a single score. These scores may help identify people at higher genetic risk, but they are not yet part of routine care.
Diabetes-type differences: Some genetic associations appear stronger in type 1 or type 2 diabetes but not both. This may help explain differences in who develops sight-threatening changes across the two groups.
Rare genetic variants: In some families, uncommon changes affecting blood vessel stability or the eye's support structure have been reported. These rare variants are not common drivers and currently do not guide routine testing.
Lifestyle risk factors
Diabetic retinopathy risk is strongly shaped by day-to-day habits that influence blood sugar, blood pressure, and inflammation. Managing diet, activity, and substance use can slow retinal damage and reduce complications. Below are key lifestyle risk factors for diabetic retinopathy and how lifestyle affects diabetic retinopathy; these are the lifestyle risk factors for diabetic retinopathy most tied to progression.
Frequent highs from skipped meals or overeating strain retinal vessels. Consistent meal planning and carb counting lower glucose swings that accelerate eye damage.
Refined carbs and desserts cause rapid glucose spikes that injure retinal capillaries. Choosing high-fiber carbs and balanced meals helps stabilize sugars and slow progression.
Sodas, juices, and sweetened coffees can sharply raise post-meal glucose. Replacing them with water or unsweetened drinks reduces glycemic load on the retina.
Sedentary time worsens insulin resistance and makes glucose harder to control. Regular aerobic and strength activity improves glucose uptake and may slow vision loss.
Risk prevention
Diabetic retinopathy risk can be lowered by steady diabetes care and timely eye checks. Prevention works best when combined with regular check-ups. Keeping blood sugar, blood pressure, and cholesterol in a healthy range helps protect the tiny blood vessels in the back of the eye. Smoking, kidney strain, and unplanned pregnancy can also raise risk, so addressing these early matters.
Keeping your A1C in your target range lowers the chance that eye blood vessels become damaged. Day-to-day stability matters as much as the average.
High blood pressure puts extra stress on the eye’s small vessels. Aim for your agreed-upon target with medication and lifestyle steps.
High LDL and triglycerides can worsen leakage in retinal vessels. Diet, exercise, and medicines like statins when needed can reduce this strain.
Get a yearly dilated eye exam, or more often if your doctor recommends it. Because early symptoms of diabetic retinopathy are often hard to notice, early checks can catch changes before vision is affected.
Transmission
People often ask if diabetic retinopathy is contagious; it isn’t—you can’t catch it from someone, and you can’t pass it on through coughing, touching, sex, or sharing items. Diabetic retinopathy develops in people with diabetes when high blood sugar over time damages the tiny blood vessels in the back of the eye.
There is no transmission route; the main drivers are how long you’ve had diabetes, how well blood sugar is managed, and factors like high blood pressure, high cholesterol, pregnancy, and smoking. Families don’t inherit diabetic retinopathy itself, but relatives may share a tendency to develop diabetes, which raises the chance of retinopathy later on.
When to test your genes
Consider genetic testing if you developed sight-threatening retinopathy unusually early, have multiple close relatives with severe diabetic eye disease, or belong to a high‑risk ancestry group where complications run strong. Testing can’t diagnose retinopathy, but it may flag inherited risk, guide screening frequency, and tailor systemic care. Discuss results with your eye specialist and a genetics professional.
Diagnosis
You might notice small changes in daily routines, like needing more light to read or having blurry spots that come and go. Doctors usually begin with a detailed eye exam and simple vision checks, then add imaging tests if needed. This stepwise approach helps confirm how diabetic retinopathy is diagnosed and guides treatment timing. Some diagnoses are clear after a single visit, while others take more time.
Your provider uses special drops to widen the pupils and looks closely at the retina and optic nerve. They check for tiny bleeds, leaky spots, and new fragile vessels that can signal damage.
Reading an eye chart shows how well you see at distance and helps track changes over time. This links symptoms to the level of retinopathy and whether the macula is affected.
This painless scan creates cross‑section images of the retina. It shows swelling in the macula and helps decide if treatments like eye injections are needed.
A small dye injection highlights blood flow in the retina as photos are taken. It maps leaking or blocked vessels and guides laser or injection treatment plans.
Stages of Diabetic retinopathy
Vision changes from diabetic retinopathy can be subtle at first, which is why regular dilated eye exams matter even when sight seems fine. Different tests may be suggested to help map out any damage in the retina and track changes over time. Many early symptoms of diabetic retinopathy are absent, but swelling of the center of the retina (macular edema) can develop at any point and affect reading or driving.
Mild nonproliferative
Small weak spots in retinal blood vessels appear, sometimes with tiny leaks your eye doctor can see. Vision is usually normal and there are often no symptoms. Routine screening often catches mild diabetic retinopathy early.
Moderate nonproliferative
More vessels become blocked or leaky, and small retinal bleeding may show up on imaging. You may notice mild blurry vision, especially when reading, but many still have no clear symptoms. Follow-up visits are scheduled more closely to watch for change.
Severe nonproliferative
Widespread vessel blockage leaves larger areas of the retina low on oxygen. The chance of progressing to proliferative diabetic retinopathy becomes high, so monitoring is frequent. Vision may still be stable, or you might have more frequent blur or dark spots.
Proliferative stage
Fragile new vessels grow on the retina and into the eye, which can bleed and cloud vision. People may see floaters, a dark curtain, or sudden vision loss, and urgent treatment is often needed. Scar tissue can pull on the retina and raise the risk of detachment.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with diabetic retinopathy, vision changes build slowly—maybe needing brighter light to read menus, or noticing blurry spots after a long day. Early care can make a real difference, because treating high blood sugar, blood pressure, and cholesterol can slow or even pause eye damage. When doctors talk about “remission,” they mean symptoms have eased or disappeared for a while.
The outlook is not the same for everyone, but most people who get regular eye exams and timely treatment keep useful vision for many years. Without care, diabetic retinopathy can progress to severe vision loss or blindness; the risk rises with longer years of diabetes, higher A1C, kidney disease, pregnancy, and smoking. Treatments like laser therapy, eye injections, and surgery don’t cure the condition, but they often stabilize or improve sight, especially when started early. People sometimes worry about mortality, but diabetic retinopathy itself isn’t usually fatal; rather, it signals higher risk of heart, kidney, and nerve complications that can affect lifespan.
Knowing what to expect can ease some of the worry. Early symptoms of diabetic retinopathy can be subtle, so yearly dilated eye exams (or more often if your eye doctor advises) are crucial. With ongoing care, many people maintain driving vision, work, and daily activities into older age. Talk with your doctor about what your personal outlook might look like, including targets for A1C and blood pressure, warning signs to watch for—like new floaters or sudden blur—and when to see a retina specialist.
Long-term effects
Diabetic retinopathy can change how you see over years, sometimes quietly at first and then more noticeably. Early symptoms of diabetic retinopathy may be subtle or even absent, which is why changes can feel sudden once they show up. Long-term effects vary widely, from mild blurriness to vision loss that affects reading, driving, and work. The outlook depends on how advanced the eye changes are and whether both eyes are involved.
Swelling near the center of the retina can make faces and print look fuzzy. Colors may look washed out, and fine details get harder to pick out.
Vision may swing from clearer to blurrier across days or weeks. These shifts often reflect ongoing changes in the retina linked to diabetic retinopathy.
You may notice new floaters, cobweb-like strands, or dark smudges. These usually come from small bleeds inside the eye.
Straight edges can look bent or rippled. For many with diabetic retinopathy, this makes reading lines of text or judging edges more difficult.
How is it to live with Diabetic retinopathy?
Living with diabetic retinopathy can feel like the world’s details are slowly fading—fine print, faces across a room, night driving—so everyday tasks take more planning and good lighting. Many find routines shift toward scheduled eye checks, steady blood sugar management, and practical adjustments like magnifiers, high-contrast labels, screen readers, and safe home layouts to prevent trips or falls. Family, friends, and coworkers often become part of the support system—offering rides after dilated exams, helping read small text, or simply understanding why breaks and consistent meals matter. With early detection, treatment, and steady diabetes care, many people keep doing what they love, just with a few smart tools and backup plans.
Treatment and drugs
Treatment for diabetic retinopathy focuses on protecting vision and slowing damage to the light‑sensing layer at the back of the eye. Good control of blood sugar, blood pressure, and cholesterol is the foundation; for many, this can mean adjusting diabetes medicines, aiming for steady glucose targets, and stopping smoking. Eye‑specific treatments include anti‑VEGF injections to reduce swelling and leaking blood vessels, steroid injections or implants for stubborn swelling, and laser therapy to seal leaks or prevent fragile new vessels from bleeding; advanced bleeding or scarring may require eye surgery called vitrectomy. Doctors sometimes recommend a combination of lifestyle changes and drugs, and the plan can change over time based on how your eyes respond. Keep track of how you feel, and share this with your care team, and don’t skip scheduled dilated eye exams, since early treatment of diabetic retinopathy often prevents vision loss.
Non-drug treatment
Non-drug care for diabetic retinopathy focuses on protecting sight by stabilizing diabetes and reducing strain from high blood sugar. Alongside medicines, non-drug therapies can lower the chance of vision loss and may slow changes seen on eye exams. These steps also support overall health, which matters for your eyes as much as for your heart and kidneys. Your eye team will tailor options based on how advanced the retinopathy is and your daily life.
Keeping glucose steady reduces ongoing damage to the tiny blood vessels in the retina. Work toward targets set with your diabetes team and check levels regularly.
Aim for your blood pressure goal to ease stress on retinal vessels. Home monitoring and regular follow-up help keep numbers in range.
Healthier cholesterol levels may slow retinal changes. Food choices and activity are first steps, with lab checks guiding progress.
Emphasize vegetables, fiber, lean protein, and fewer ultra-processed foods to support glucose and blood pressure. Some strategies can slip naturally into your routine—like adding a vegetable to each meal or planning balanced snacks.
Your genes may have an impact on how drugs work for you
Medicines for diabetic retinopathy can work differently based on your genes, which can shape how you absorb, break down, and respond to treatments like anti-VEGF injections or corticosteroids. Genetic differences may affect dosing needs, side effects, and which therapy works best.
Pharmacological treatments
Medicines can help control swelling, bleeding, and leaky blood vessels in diabetic retinopathy, especially when vision is at risk. Most treatments are injections placed into the eye by a retina specialist; some are slow-release implants, and a few are taken by mouth. Not everyone responds to the same medication in the same way. Even before early symptoms of diabetic retinopathy show up, treatment choices are tailored to the eye exam and imaging.
This anti-VEGF eye injection reduces fluid in the macula and blocks abnormal vessel growth. It is often used for center-involving diabetic macular edema and for active proliferative disease. Many start with monthly doses, then extend intervals if the retina stays stable.
An anti-VEGF injection approved to treat diabetic macular edema and diabetic retinopathy. It can improve or stabilize vision when swelling is reduced. Treatment frequency may be adjusted based on how your eye responds.
An off-label anti-VEGF option that is widely used because it’s effective for many and more affordable. Injections are repeated over time to keep fluid and bleeding under control. Your doctor will monitor vision and retinal imaging to guide timing.
Targets both VEGF and Ang-2 to reduce leakage and stabilize fragile vessels. Some people can go longer between injections once swelling and bleeding are controlled. It is used for diabetic macular edema and diabetic retinopathy with active changes.
Genetic influences
Genes don’t cause diabetic retinopathy on their own, but they can tilt risk up or down in people living with diabetes. Even when two people have had diabetes for the same length of time and keep similar blood sugar levels, one may develop vision‑threatening changes while the other does not—differences in inherited biology likely play a role. Family history is one of the strongest clues to a genetic influence. Studies suggest that gene changes tied to blood vessel growth, inflammation, and how the body handles high glucose can affect who gets diabetic retinopathy and how severe it becomes. Genetics do not change what early symptoms of diabetic retinopathy feel like—such as blurred vision or trouble seeing at night—but they may influence how quickly damage builds and how you respond to treatment. Because genes are only one piece, managing blood sugar, blood pressure, and cholesterol remains the most powerful way to lower risk, and asking about genetic counseling or research studies may be helpful if many relatives are affected.
Is Diabetic retinopathy genetic?
Genetics plays a modest role in diabetic retinopathy risk, influencing susceptibility, severity, and how quickly changes progress. Still, blood sugar, blood pressure, and duration of diabetes matter more. Family history can guide screening, but routine clinical management remains the priority.
Pharmacogenetics—how genetics influence drug effects
People with diabetic retinopathy can respond very differently to the same eye injections or steroid implants. Not every difference in response is genetic, but research suggests inherited differences in pathways that drive new blood vessel growth and inflammation may help explain why anti-VEGF drugs or steroids work better for some than others. This area, called pharmacogenetics, looks at how your genes may shape treatment effect and side effects, including a steroid-related rise in eye pressure that can run in families. Scientists are exploring genetic markers that might predict who benefits most from a given anti-VEGF medicine in diabetic retinopathy, yet findings are mixed and not ready for everyday care.
Right now, there isn’t a routine DNA test to choose the best drug or dose for diabetic retinopathy. Doctors usually decide based on your eye exam and scans, blood sugar control, and how your vision and swelling change over time, while watching for known risks like pressure spikes after steroids.
Interactions with other conditions
High blood pressure or high cholesterol can put extra strain on the eye’s tiny vessels, so diabetic retinopathy may progress faster when these are not well controlled. Doctors call it a “comorbidity” when two conditions occur together. Kidney disease linked to diabetes often goes hand in hand with diabetic retinopathy because both involve small‑vessel damage; when the kidneys are affected, eye findings are often more severe, too. Heart and blood vessel disease share many of the same risk factors, and having diabetic retinopathy is also a marker of higher risk for heart attack and stroke. Obstructive sleep apnea and anemia can reduce oxygen delivery to the retina and may worsen swelling or bleeding, while pregnancy can make diabetic retinopathy change more quickly, so closer eye monitoring is recommended. Coordinated care for blood sugar, blood pressure, cholesterol, kidney health, and sleep apnea helps protect vision, and because early symptoms of diabetic retinopathy can be easy to miss, regular dilated eye exams are important even when sight seems normal.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described changes in eyesight that followed years of living with diabetes: lamp flames haloed at night, print blurring by afternoon, colors seeming washed out. Family letters and clinic notes from the 1800s mention slow vision loss after frequent thirst and weight changes, long before doctors had today’s blood tests. Eye doctors began to notice tiny spots of bleeding on the retina during exam, a pattern that linked long-standing diabetes to progressive eye damage.
First described in the medical literature as “retinal changes of diabetes” in the late 19th century, the condition later gained a clear identity as photography of the back of the eye improved. Early fundus cameras in the 1920s and 1930s captured the telltale dots, blots, and fragile new vessels. Over time, descriptions became more precise: “background” changes when the smallest vessels leaked, and “proliferative” disease when new, breakable vessels sprouted and bled. These terms reflected what doctors could see, even before they understood the chemistry of high glucose and vessel injury.
In the mid-20th century, as insulin became widely available and people lived longer with diabetes, diabetic retinopathy appeared more often, prompting large studies. Researchers followed thousands of patients, showing that tighter blood sugar control lowered the risk of vision-threatening changes. In recent decades, knowledge has built on a long tradition of observation. Fluorescein angiography mapped leaking vessels; optical coherence tomography provided near-microscopic, cross‑section images of swelling in the macula, the sharp-seeing center of the retina.
Treatment history moved from careful observation to lasers and then to targeted medicines. In the 1960s and 1970s, panretinal laser therapy reduced bleeding from fragile new vessels and prevented severe vision loss for many. Later, focal lasers addressed macular swelling. The 2000s brought anti-VEGF injections—medicines that act like turning down a stuck-on growth signal—improving vision for many with macular edema and active new vessel growth. Today, combinations of careful glucose and blood pressure control, regular screening photos, and modern treatments mean more people with diabetic retinopathy keep useful vision.
Across cultures and centuries, diabetic retinopathy has been observed in different ways. Understandings have changed, but one theme holds: early detection matters. The story continues to evolve with artificial intelligence reading retinal images, wider access to tele‑screening in clinics and pharmacies, and ongoing studies that refine how often eyes should be checked. Looking back helps explain why regular eye exams are emphasized so strongly today—and why even without symptoms, screening can catch early signs of diabetic retinopathy before vision is affected.